Companies: 49,360 Total Market Cap: 132699690609299.18

Australian Clinical Labs Limited

ASX-ACL
Healthcare Diagnostics & Research
Rank #16033
Market Cap 355.97 M
Volume 893,761
Price 1.83
Change (%) 1.05%
Country or region Australia Australia

Australian Clinical Labs Limited's latest marketcap:

355.97 M

As of 06/03/2025, Australian Clinical Labs Limited's market capitalization has reached $355.97 M. According to our data, Australian Clinical Labs Limited is the 16033th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.

Market Cap 355.97 M
Revenue (ttm) 473.03 M
Net Income (ttm) 19.92 M
Shares Out 194.35 M
EPS (ttm) 0.10
Forward PE 14.70
Ex-Dividend Date 03/27/2025
Earnings Date 08/26/2025
Market Cap Chart
Data Updated: 06/03/2025

Australian Clinical Labs Limited's yearly market capitalization.

Australian Clinical Labs Limited has seen its market value drop from A$1.25 B to A$548.06 M since 2021, representing a total decrease of 56.20% and an annual compound decline rate (CAGR) of 21.44%.
Date Market Cap Change (%)
06/03/2025 A$548.06 M -15.98%
12/31/2024 A$684.50 M 18.13%
12/29/2023 A$579.45 M -3.17%
12/30/2022 A$598.41 M -52.18%
12/31/2021 A$1.25 B

Company Profile

About Australian Clinical Labs Limited

Australian Clinical Labs Limited is a leading provider of pathology diagnostic services across Australia. Established in 2020 and headquartered in Clayton, the company delivers a comprehensive range of medical testing solutions to both private and public healthcare facilities.

Key Services Offered

  • Routine & Advanced Testing: Includes pathology tests, molecular genetics, and first-trimester screenings.
  • Specialized Diagnostics: Covers chemical pathology, histopathology, cytopathology, and hematology.
  • Allergy & Immunology: Comprehensive testing for immune system and allergic conditions.
  • Infectious Disease & Microbiology: Serology, microbiology, and molecular infectious disease testing.
  • Additional Services: Cardiac testing, functional pathology, veterinary pathology, and drug/alcohol screening.

With a commitment to precision and innovation, Australian Clinical Labs supports healthcare providers with reliable diagnostic solutions.

Frequently Asked Questions

As of 06/03/2025, Australian Clinical Labs Limited (including the parent company, if applicable) has an estimated market capitalization of $355.97 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.

Australian Clinical Labs Limited global market capitalization ranking is approximately 16033 as of 06/03/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.

Stock Detail

Country or region Australia
Founded 2020
IPO Date n/a
Employees 4,900
CEO Melinda McGrath
Sector Healthcare
Industry Diagnostics & Research
Address 1868-1892 Dandenong Road
Clayton, 3168
Australia
Website https://www.clinicallabs.com.au
People Also Watch
TMO
396.47 1.05%
Danaher
189.23 1.05%
Lonza Group AG
695.68 1.05%
IDXX
514.80 1.05%